Literature DB >> 3945888

Hepatic resection for metastases of the colon and rectum.

J Butler, F F Attiyeh, J M Daly.   

Abstract

Hepatic resection is the treatment of choice for a solitary metastatic deposit from a primary carcinoma of the large intestine in the absence of extrahepatic disease. This study was done to evaluate hepatic resection in the treatment of multiple hepatic metastases from carcinoma of the colon and rectum. Sixty-two patients underwent hepatic resection with an over-all operative mortality of 10 per cent, but a recent (1968-1981) mortality of 2 per cent. Three, five and ten year survival rates were 50, 34 and 21 per cent, respectively. No significant differences in survival patterns were noted comparing site (colon versus rectum), time interval from diagnosis of the primary to diagnosis of metastases (synchronous versus metachronous), sex (male versus female), size of the metastatic lesion (less than 5 centimeters versus greater than or equal to 5 centimeters) or number of metastatic lesions (single versus multiple). The pathologic stage of the primary carcinoma of the large intestine significantly (p less than 0.05) influenced survival patterns after hepatic resection with Dukes' B primary tumor having a median survival time of 123 months versus 27 months for patients with Dukes' C primary tumor. Sixty-seven per cent of those with a recurrence did so within the liver. Adjuvant chemotherapy had no demonstrable effect on survival patterns. Further improvement in survival statistics will require more sensitive staging procedures and effective adjuvant therapy, particularly for patients with Dukes' C primary carcinoma of the large intestine.

Entities:  

Mesh:

Year:  1986        PMID: 3945888

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  41 in total

1.  Hepatic resection at a community hospital.

Authors:  M E Ston; S U Rehman; G Conaway; A Sardi
Journal:  J Gastrointest Surg       Date:  2000 Jul-Aug       Impact factor: 3.452

2.  Hepatic arterial infusion after curative resection of colorectal cancer metastases: a meta-analysis of prospective clinical trials.

Authors:  Thomas E Clancy; Elijah Dixon; Roy Perlis; Francis R Sutherland; Michael J Zinner
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

Review 3.  Resection of colorectal liver metastases revisited.

Authors:  J Scheele; C Rudroff; A Altendorf-Hofmann
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

4.  Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)

Authors:  M Lorenz; H H Müller; H Schramm; H J Gassel; H G Rau; K Ridwelski; J Hauss; R Stieger; K W Jauch; W O Bechstein; A Encke
Journal:  Ann Surg       Date:  1998-12       Impact factor: 12.969

Review 5.  History and present status of pulmonary metastasectomy in colorectal cancer.

Authors:  Tom Treasure; Mišel Milošević; Francesca Fiorentino; Joachim Pfannschmidt
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 6.  Resection of liver metastases from a colorectal carcinoma does not benefit the patient.

Authors:  T M Hunt; N Carty; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1990-05       Impact factor: 1.891

7.  Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients.

Authors:  J V Sitzmann; P S Greene
Journal:  Ann Surg       Date:  1994-01       Impact factor: 12.969

8.  Liver resection for metastatic colorectal cancer.

Authors:  S Iwatsuki; C O Esquivel; R D Gordon; T E Starzl
Journal:  Surgery       Date:  1986-10       Impact factor: 3.982

9.  Repeat hepatic surgery for colorectal cancer metastasis to the liver.

Authors:  C W Pinson; J K Wright; W C Chapman; C L Garrard; T K Blair; J L Sawyers
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

Review 10.  Resection of hepatic metastases from colorectal cancer. Biologic perspective.

Authors:  G Steele; T S Ravikumar
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.